eLife (Feb 2016)
Regulatory polymorphisms modulate the expression of HLA class II molecules and promote autoimmunity
- Prithvi Raj,
- Ekta Rai,
- Ran Song,
- Shaheen Khan,
- Benjamin E Wakeland,
- Kasthuribai Viswanathan,
- Carlos Arana,
- Chaoying Liang,
- Bo Zhang,
- Igor Dozmorov,
- Ferdicia Carr-Johnson,
- Mitja Mitrovic,
- Graham B Wiley,
- Jennifer A Kelly,
- Bernard R Lauwerys,
- Nancy J Olsen,
- Chris Cotsapas,
- Christine K Garcia,
- Carol A Wise,
- John B Harley,
- Swapan K Nath,
- Judith A James,
- Chaim O Jacob,
- Betty P Tsao,
- Chandrashekhar Pasare,
- David R Karp,
- Quan Zhen Li,
- Patrick M Gaffney,
- Edward K Wakeland
Affiliations
- Prithvi Raj
- Department of Immunology, University of Texas Southwestern Medical Center, Dallas, United States
- Ekta Rai
- Department of Immunology, University of Texas Southwestern Medical Center, Dallas, United States; School of Biotechnology, Shri Mata Vaishno Devi University, Katra, India
- Ran Song
- Department of Immunology, University of Texas Southwestern Medical Center, Dallas, United States
- Shaheen Khan
- Department of Immunology, University of Texas Southwestern Medical Center, Dallas, United States
- Benjamin E Wakeland
- Department of Immunology, University of Texas Southwestern Medical Center, Dallas, United States
- Kasthuribai Viswanathan
- Department of Immunology, University of Texas Southwestern Medical Center, Dallas, United States
- Carlos Arana
- Department of Immunology, University of Texas Southwestern Medical Center, Dallas, United States
- Chaoying Liang
- Department of Immunology, University of Texas Southwestern Medical Center, Dallas, United States
- Bo Zhang
- Department of Immunology, University of Texas Southwestern Medical Center, Dallas, United States
- Igor Dozmorov
- Department of Immunology, University of Texas Southwestern Medical Center, Dallas, United States
- Ferdicia Carr-Johnson
- Department of Immunology, University of Texas Southwestern Medical Center, Dallas, United States
- Mitja Mitrovic
- Department of Neurology, Yale School of Medicine, New Haven, United States
- Graham B Wiley
- Arthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, United States
- Jennifer A Kelly
- Arthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, United States
- Bernard R Lauwerys
- Pole de pathologies rhumatismales, Institut de Recherche Expérimentale et Clinique, Université catholique de Louvain, Bruxelles, Belgium
- Nancy J Olsen
- Division of Rheumatology, Department of Medicine, Penn State Medical School, Hershey, United States
- Chris Cotsapas
- Department of Neurology, Yale School of Medicine, New Haven, United States
- Christine K Garcia
- Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, United States; Eugene McDermott Center for Human Growth and Development, University of Texas Southwestern Medical Center, Dallas, United States
- Carol A Wise
- Eugene McDermott Center for Human Growth and Development, University of Texas Southwestern Medical Center, Dallas, United States; Department of Orthopaedic Surgery, University of Texas Southwestern Medical Center, Dallas, United States; Sarah M. and Charles E. Seay Center for Musculoskeletal Research, Texas Scottish Rite Hospital for Children, Dallas, United States; Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, United States
- John B Harley
- Cincinnati VA Medical Center, Cincinnati, United States; Cincinnati Children's Hospital Medical Center, Cincinnati, United States
- Swapan K Nath
- Arthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, United States
- Judith A James
- Arthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, United States
- Chaim O Jacob
- Department of Medicine, University of Southern California, Los Angeles, United States
- Betty P Tsao
- Department of Medicine, University of California, Los Angeles, Los Angeles, United States
- Chandrashekhar Pasare
- Department of Immunology, University of Texas Southwestern Medical Center, Dallas, United States
- David R Karp
- Rheumatic Diseases Division, Department of Medicine, University of Texas Southwestern Medical Center, Dallas, United States
- Quan Zhen Li
- Department of Immunology, University of Texas Southwestern Medical Center, Dallas, United States
- Patrick M Gaffney
- Arthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, United States
- Edward K Wakeland
- ORCiD
- Department of Immunology, University of Texas Southwestern Medical Center, Dallas, United States
- DOI
- https://doi.org/10.7554/eLife.12089
- Journal volume & issue
-
Vol. 5
Abstract
Targeted sequencing of sixteen SLE risk loci among 1349 Caucasian cases and controls produced a comprehensive dataset of the variations causing susceptibility to systemic lupus erythematosus (SLE). Two independent disease association signals in the HLA-D region identified two regulatory regions containing 3562 polymorphisms that modified thirty-seven transcription factor binding sites. These extensive functional variations are a new and potent facet of HLA polymorphism. Variations modifying the consensus binding motifs of IRF4 and CTCF in the XL9 regulatory complex modified the transcription of HLA-DRB1, HLA-DQA1 and HLA-DQB1 in a chromosome-specific manner, resulting in a 2.5-fold increase in the surface expression of HLA-DR and DQ molecules on dendritic cells with SLE risk genotypes, which increases to over 4-fold after stimulation. Similar analyses of fifteen other SLE risk loci identified 1206 functional variants tightly linked with disease-associated SNPs and demonstrated that common disease alleles contain multiple causal variants modulating multiple immune system genes.
Keywords